Tesamorelin
Egrifta, TH9507
A synthetic growth hormone-releasing hormone analog used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy.
Completed
PHASE2
NCT00675506
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT03226821
Body Composition and Adipose Tissue in HIV
Columbia University
INTERVENTIONAL
Updated Dec 15, 2025
Withdrawn
NCT01788462
Egrifta Replacement and Sleep Disordered Breathing
Johns Hopkins University
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03375788
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025